For research designs that require multiple administrations, nasal sprays provide a practical concept of peptide therapy with reduced side effects compared using the epithalon peptide vial
While still under investigation, early studies suggest these medications may play a role in slowing certain neurodegenerative processes such as those associated with Alzheimers disease
These findings suggest that Epitalon helps maintain the cytoskeletal and organelle architecture essential for oocyte competence [2]
Besides, dual GLP-1/GIP receptor agonists (DA-JC4, DA5-CH, DA-JC1 and DA-CH3) reduced inflammation response, amyloid plaques and tau phosphorylation in brain, reversed memory loss, and enhanced synaptic plasticity in hippocampus of APP/PS1 mice (186, 234, 236, 238)